This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

PHARMACORP ANNOUNCES CLOSING OF C$11.5 MILLION BOUGHT DEAL PUBLIC OFFERING

Newswire.ca - Tue Jul 14, 8:27AM CDT

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

SASKATOON, SK, July 14, 2026 /CNW/ - PharmaCorp Rx Inc. ("PharmaCorp" or the "Company") (TSXV: PCRX) is pleased to announce that it has closed its previously announced bought deal public offering co-led by Acumen Capital Finance Partners Limited and Canaccord Genuity Corp., and including Raymond James Ltd. (collectively, the "Underwriters") pursuant to which the Underwriters purchased, on a bought deal basis, 22,549,200 units (the "Units") in the capital of the Company at a price of C$0.51 per Unit (the "Offering Price") for aggregate gross proceeds to the Company of approximately C$11.5 million, which includes the full exercise of the Underwriters over-allotment option (the "Offering").

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Market data provided by Barchart. Exchange delay details and data provider terms here. Information may be delayed, is provided 'as is' and is solely for informational purposes, and not for trading, investment or advice.